The study further investigated the underlying mechanisms of the SPARC family's impact on LGG prognosis, including their interactions with genomic and epigenomic factors, their influence on glioma stem cells (GSCs), and their role in the immune response. The gene discussed is SPARC; the disease is central nervous system cancer.